Pregnancy can impact Factor V Leiden treatment by increasing the risk of clot-related complications. Women with the mutation may require adjustments to their treatment plan during pregnancy to minimize these risks. Regular monitoring, preventive measures, and consultation with healthcare providers are crucial during this period.